811 Shares in Waters Co. (NYSE:WAT) Purchased by Syon Capital LLC

Syon Capital LLC acquired a new stake in Waters Co. (NYSE:WAT - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor acquired 811 shares of the medical instruments supplier's stock, valued at approximately $301,000.

Other hedge funds have also recently added to or reduced their stakes in the company. Aster Capital Management DIFC Ltd bought a new position in shares of Waters in the 4th quarter valued at $28,000. Bank of Jackson Hole Trust bought a new position in Waters in the fourth quarter valued at about $34,000. Fortitude Family Office LLC boosted its stake in shares of Waters by 235.7% during the fourth quarter. Fortitude Family Office LLC now owns 94 shares of the medical instruments supplier's stock valued at $35,000 after purchasing an additional 66 shares in the last quarter. Steward Partners Investment Advisory LLC grew its holdings in shares of Waters by 129.3% during the fourth quarter. Steward Partners Investment Advisory LLC now owns 94 shares of the medical instruments supplier's stock worth $35,000 after purchasing an additional 53 shares during the last quarter. Finally, Murphy & Mullick Capital Management Corp acquired a new position in shares of Waters in the fourth quarter valued at approximately $42,000. Institutional investors and hedge funds own 94.01% of the company's stock.

Wall Street Analyst Weigh In

A number of equities research analysts have weighed in on WAT shares. StockNews.com lowered shares of Waters from a "buy" rating to a "hold" rating in a report on Tuesday, February 25th. Baird R W upgraded Waters from a "hold" rating to a "strong-buy" rating in a report on Wednesday, March 26th. Bank of America cut their target price on Waters from $430.00 to $410.00 and set a "neutral" rating on the stock in a report on Thursday, February 13th. KeyCorp upgraded Waters from a "sector weight" rating to an "overweight" rating and set a $460.00 price target on the stock in a research report on Monday, March 31st. Finally, UBS Group raised their price objective on Waters from $405.00 to $410.00 and gave the stock a "neutral" rating in a research report on Thursday, February 13th. Ten research analysts have rated the stock with a hold rating, seven have given a buy rating and two have given a strong buy rating to the company's stock. According to MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $392.13.

Waters Stock Up 0.7 %

NYSE:WAT traded up $2.21 during trading hours on Monday, reaching $340.10. The company had a trading volume of 308,163 shares, compared to its average volume of 474,776. Waters Co. has a twelve month low of $279.24 and a twelve month high of $423.56. The company has a quick ratio of 0.65, a current ratio of 0.94 and a debt-to-equity ratio of 1.14. The firm has a market cap of $20.23 billion, a price-to-earnings ratio of 31.76, a P/E/G ratio of 3.79 and a beta of 1.04. The business's 50-day simple moving average is $355.22 and its two-hundred day simple moving average is $370.45.

Waters (NYSE:WAT - Get Free Report) last issued its earnings results on Wednesday, February 12th. The medical instruments supplier reported $4.10 EPS for the quarter, beating the consensus estimate of $4.02 by $0.08. Waters had a return on equity of 46.31% and a net margin of 21.56%. On average, equities analysts expect that Waters Co. will post 12.86 earnings per share for the current year.

About Waters

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.